Delivery Order SPE2DR25D7068-SPE2DR26F5CJ7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,214.44 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% foam (10 grams) on December 14, 2025, with an ultimate completion date of December 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam (10GM) on December 11, 2025, with a ceiling value of $1,045.34 under a firm fixed price contract. This non-set-aside competitive award was issued to the company's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 12, 2025. The delivery order represents a discrete purchase under AmerisourceBergen Drug Corp's broader pharmaceutical...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram formulation, with a ceiling value of $3,251.10 under firm fixed pricing. This non-set-aside competitive award represents a child contract delivery order with an ultimate completion date of September 5, 2025, and is performed out of the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,217.64 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This competitive award, issued on January 5, 2026, with an ultimate completion date of January 6, 2026, utilizes firm fixed-price pricing under a delivery order contract type with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This...
- The Defense Logistics Agency awarded a $11,418.86 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Proctofoam-HC 1%-1% Foam in 10-gram units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 16, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $1,014.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit on December 19, 2025, with an ultimate completion date of December 22, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The award carried no set-aside designation...
- The Defense Logistics Agency awarded a $3,772.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units. This contract, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a non-competitive, non-set-aside award. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a non-set-aside, competitively awarded contract with a firm fixed price ceiling value of $2,891.69 and an ultimate completion date of September 23, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,119.18 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit on September 24, 2025, with an ultimate completion date of September 25, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award was performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram formulation, valued at $3,027.91 with a firm fixed price structure. This is a non-set-aside contract utilizing competitive procurement procedures, with performance scheduled to conclude by November 3, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance. This delivery order is issued under the...
- SPE2DR25D7068Indefinite Delivery Contract
- SPE2DR25D7068-SPE2DR26F5CJ7Delivery Order
On January 6, 2026, the Defense Logistics Agency awarded a delivery order valued at $2,320.30 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram quantities. This non-competitive delivery order, which will be completed by January 7, 2026, represents a firm fixed-price procurement of a topical pharmaceutical product. The award is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc. (doing business as AmerisourceBergen), which holds a substantial indefinite delivery contract with DLA Troop Support Medical valued at $999.99 million through December 2031. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a task order under the larger DLA pharmaceutical supply vehicle, which provides a comprehensive source for brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally. AmerisourceBergen's extensive federal contract portfolio demonstrates the company's established capability to deliver critical pharmaceutical products across multiple therapeutic domains to military treatment facilities, Veterans Affairs programs, and other federal medical institutions. The Proctofoam product being procured is a rectal foam medication used in the treatment of hemorrhoids and similar rectal conditions, reflecting the breadth of medical supplies the company provides through its federal contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 1/5/26 |